Evidence map›Paper›PMID 32796537›Full record

ReviewInternational journal of molecular sciences2020

Towards the Development of AgoKirs: New Pharmacological Activators to Study K

Laura van der Schoor, Emma J van Hattum, Sophie M de Wilde, Netanja I Harlianto, Aart-Jan van Weert, Meye Bloothooft, Marcel A G van der Heyden

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Molecular mechanisms of Kir channel gating.Biochemical Society transactions · 2026
    Review
  3. Article
  4. Article
  5. Chronic Propafenone Application Increases Functional KPharmaceuticals (Basel, Switzerland) · 2023
    Article
  6. Development of IFrontiers in pharmacology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Laura van der SchoorHonours Program CRU+ Bachelor, University Medical Center Utrecht, Heidelberglaan 100, 3584 CM Utrecht, The Netherlands.
Emma J van HattumHonours Program CRU+ Bachelor, University Medical Center Utrecht, Heidelberglaan 100, 3584 CM Utrecht, The Netherlands.
Sophie M de WildeHonours Program CRU+ Bachelor, University Medical Center Utrecht, Heidelberglaan 100, 3584 CM Utrecht, The Netherlands.
Netanja I HarliantoHonours Program CRU+ Bachelor, University Medical Center Utrecht, Heidelberglaan 100, 3584 CM Utrecht, The Netherlands.
Aart-Jan van WeertHonours Program CRU+ Bachelor, University Medical Center Utrecht, Heidelberglaan 100, 3584 CM Utrecht, The Netherlands.
Meye BloothooftDepartment of Medical Physiology, Division of Heart & Lungs, University Medical Center Utrecht, Yalelaan 50, 3584 CM Utrecht, The Netherlands.
Marcel A G van der HeydenDepartment of Medical Physiology, Division of Heart & Lungs, University Medical Center Utrecht, Yalelaan 50, 3584 CM Utrecht, The Netherlands.ORCID 0000-0002-4225-7942
Heidelberg University · DEUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inward rectifier potassium ion channels (I

Indexed as

AnimalsHeart DiseasesHumansIon Channel GatingPotassium Channels, Inwardly RectifyingPotassium Channels, Inwardly RectifyingagonistAndersen syndromeheart failureIK1inward rectifier channelKir2

Identifiers

PMID32796537
PMCPMC7461056
OpenAlexW3048862602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.